Synapsoft logo
AI Insights from Disclosures
Searching...
ST PHARM CO., LTD. 237690
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
ST PHARM CO., LTD. began as Samchully Pharm, founded in 1983, and was incorporated into Dong-A Socio Group in 2010, and based on its experience and technology in small-molecule new drug CDMO, it expanded its business into oligonucleotide therapeutics CDMO, a new therapeutic area. In 2018, the company completed a new plant dedicated to oligonucleotide therapeutics at its Banwol Campus, giving it the world's third-largest oligo production capacity.
Representative Director Sung Moo-je
Founded August 18, 2008
Corporation Type KOSDAQ
Industry Classification Manufacture of medicaments
Corporate number 15451-0039704
Business number 303-81-52269
Phone Number 02-527-6300
Fax Number 02-561-6006
Company Address 231 Hyeomnyeok-ro, Siheung-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant